González-Peñas E, Martinez P, Gimeno M, Coronel P
Organic Chemistry, Research Center in Applied Pharmacobiology (CIFA), University of Navarra, Spain.
Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):213-7. doi: 10.1007/BF03189342.
Numerous oral iron preparations are available for the treatment of iron deficiency anemia but only very few studies have been designed to measure the bioavailability of iron preparations. The aim of this assay is to determine the bioavailability of iron formulated as natural ferric protein (TM/FMOA)(FMOA=Ferrimannitol ovalbumin) and natural ferric protein with folic acid (TM/FMOA+FOL) in healthy and anemic rats. Determination of the bioavailability of iron has been carried out by studying the serum level-time curves after i.v. administration of a single dose of 1 mg iron/kg in the form of ferrous sulfate, and after oral administration of 2 mg of iron/kg in the form of TM/FMOA or TM/FMOA+FOL. The Cmax values obtained after oral administration of TM/FMOA and TM/FMOA+FOL are greater in the case of anemic rats, while the tmax values are similar in both types of animals. The bioavailability (F) is greater for the anemic rats (80% approx), and the presence of folic acid does not appear to influence the bioavailability of the iron. This bioavailability data with TM/FMOA can predict good results in further experiments in human beings with iron deficiencies.
有多种口服铁制剂可用于治疗缺铁性贫血,但仅有极少数研究旨在测定铁制剂的生物利用度。本试验的目的是测定天然铁蛋白(TM/FMOA)(FMOA = 铁甘露醇卵清蛋白)和含叶酸的天然铁蛋白(TM/FMOA + FOL)在健康大鼠和贫血大鼠体内的铁生物利用度。通过研究静脉注射1 mg铁/kg硫酸亚铁单剂量后以及口服2 mg铁/kg TM/FMOA或TM/FMOA + FOL后的血清水平-时间曲线来测定铁的生物利用度。口服TM/FMOA和TM/FMOA + FOL后,贫血大鼠获得的Cmax值更高,而两种类型动物的tmax值相似。贫血大鼠的生物利用度(F)更高(约80%),叶酸的存在似乎不影响铁的生物利用度。TM/FMOA的这种生物利用度数据可预测在缺铁人类的进一步实验中会取得良好结果。